• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Akorn Pharmaceuticals - Articles and news items

Allergan receives Paragraph IV notification on Restasis

Industry news / 16 July 2015 / Victoria White

Akorn Pharmaceuticals seeks approval to market a generic version of Allergan’s Restasis from the US Food and Drug Administration FDA…


Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +